Onderneming Gracell Biotechnologies Inc.
Aandelen
GRCL
US38406L1035
Biotechnologie & Medisch Onderzoek
Vakgebied
Aantal werknemers: 314
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Wei Cao
CEO | Chief Executive Officer | 66 | 01-05-17 |
Yi Li Xie
DFI | Director of Finance/CFO | 54 | 24-07-20 |
Wendy Li
CTO | Chief Tech/Sci/R&D Officer | 66 | 01-08-22 |
Gracie Tong
IRC | Investor Relations Contact | - | - |
Samuel Zhang
PRN | Corporate Officer/Principal | - | 19-07-22 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Wei Cao
CEO | Chief Executive Officer | 66 | 01-05-17 |
Guo Tong Xu
BRD | Director/Board Member | 67 | 01-02-19 |
Guo Wei Wang
BRD | Director/Board Member | 63 | 01-03-20 |
Kin Ping Lee
BRD | Director/Board Member | 56 | 09-07-21 |
Wendy Hayes
BRD | Director/Board Member | 54 | 07-01-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 0 | 61 364 562 | 0 | 0 | 83,58 % |
Aandeel B | 0 | 59 327 653 | 0 | 0 | |
Aandeel C | 1 | 479 632 139 | 400 876 542 ( 83,58 %) | 0 | |
Aandeel D | 0 | 21 735 721 | 0 | 0 | |
Aandeel E | 0 | 31 343 284 | 0 | 0 |
Bedrijfsgegevens
Gracell Biotechnologies, Inc.
Biobay & Suzhou Industrial Park 218 Sangtian Street
215123, Suzhou
+
http://www.gracellbio.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+1,51% | 42,75 mld. | |
+49,22% | 41,61 mld. | |
+8,57% | 41,34 mld. | |
-12,36% | 26,59 mld. | |
+8,92% | 25,49 mld. | |
-25,13% | 18,12 mld. | |
+29,17% | 12,24 mld. | |
-3,12% | 11,76 mld. | |
+6,35% | 11 mld. |